TSHATaysha Gene Therapies, Inc.Mar 19, 2026Q4 2025
Read transcript →Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$6.30
-2.55%
Mkt Cap $1.60B
TSHATaysha Gene Therapies, Inc.Mar 19, 2026TSHATaysha Gene Therapies, Inc.Nov 4, 2025Q3 2025
Read transcript →TSHATaysha Gene Therapies, Inc.Aug 12, 2025Q2 2025
Read transcript →TSHATaysha Gene Therapies, Inc.May 15, 2025Q1 2025
Read transcript →TSHATaysha Gene Therapies, Inc.Feb 26, 2025Q4 2024
Read transcript →TSHATaysha Gene Therapies, Inc.Nov 13, 2024Q3 2024
Read transcript →TSHATaysha Gene Therapies, Inc.Aug 12, 2024Q2 2024
Read transcript →TSHATaysha Gene Therapies, Inc.May 14, 2024Q1 2024
Read transcript →TSHATaysha Gene Therapies, Inc.Mar 19, 2024Q4 2023
Read transcript →TSHATaysha Gene Therapies, Inc.Nov 14, 2023Q3 2023
Read transcript →TSHATaysha Gene Therapies, Inc.Aug 14, 2023Q2 2023
Read transcript →TSHATaysha Gene Therapies, Inc.May 11, 2023Q1 2023
Read transcript →TSHATaysha Gene Therapies, Inc.Mar 28, 2023Q4 2022
Read transcript →TSHATaysha Gene Therapies, Inc.Nov 13, 2022Q3 2022
Read transcript →TSHATaysha Gene Therapies, Inc.Aug 13, 2022Q2 2022
Read transcript →TSHATaysha Gene Therapies, Inc.May 16, 2022Q1 2022
Read transcript →TSHATaysha Gene Therapies, Inc.Mar 31, 2022Q4 2021
Read transcript →TSHATaysha Gene Therapies, Inc.Nov 10, 2021Q3 2021
Read transcript →TSHATaysha Gene Therapies, Inc.Aug 16, 2021Q2 2021
Read transcript →TSHATaysha Gene Therapies, Inc.May 11, 2021Q1 2021
Read transcript →